215 related articles for article (PubMed ID: 37069592)
1. Evidence requirements of permanently listed digital health applications (DiGA) and their implementation in the German DiGA directory: an analysis.
Mäder M; Timpel P; Schönfelder T; Militzer-Horstmann C; Scheibe S; Heinrich R; Häckl D
BMC Health Serv Res; 2023 Apr; 23(1):369. PubMed ID: 37069592
[TBL] [Abstract][Full Text] [Related]
2. [Support for innovation at the BfArM-experiences from the consultations on digital health applications (DiGA)].
Löbker W; Böhmer AC; Höfgen B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1241-1248. PubMed ID: 34519834
[TBL] [Abstract][Full Text] [Related]
3. [Digital health applications (DiGA): assessment of reimbursability by means of the "DiGA Fast Track" procedure at the Federal Institute for Drugs and Medical Devices (BfArM)].
Lauer W; Löbker W; Höfgen B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1232-1240. PubMed ID: 34529095
[TBL] [Abstract][Full Text] [Related]
4. [The new approval process for the reimbursement of digital health applications (DiGA) from the perspective of the German statutory health insurance].
Gregor-Haack J; Busse T; Hagenmeyer EG
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1220-1227. PubMed ID: 34459939
[TBL] [Abstract][Full Text] [Related]
5. Digital health applications from a government-regulated directory of reimbursable health apps in Germany-a systematic review for evidence and bias.
Dittrich F; Mielitz A; Pustozerov E; Lawin D; von Jan U; Albrecht UV
Mhealth; 2023; 9():35. PubMed ID: 38023782
[TBL] [Abstract][Full Text] [Related]
6. [Experiences of digital health care applications (DIGA) manufacturers with the BfArM Fast-Track procedure].
Heimann P; Lorenz N; Blum N; Schifferings C
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1249-1253. PubMed ID: 34542649
[TBL] [Abstract][Full Text] [Related]
7. [Critical Evaluation of Permanently Listed Psychosocial Digital Health Applications into the Directory for Reimbursable Digital Health Applications of the BfArM].
Wolff LL; Rapp M; Mocek A
Psychiatr Prax; 2023 Mar; 50(2):67-79. PubMed ID: 36170874
[TBL] [Abstract][Full Text] [Related]
8. [How robust are studies of currently permanently included digital health applications (DiGA)? Methodological quality of studies demonstrating positive health care effects of DiGA].
Kolominsky-Rabas PL; Tauscher M; Gerlach R; Perleth M; Dietzel N
Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():1-16. PubMed ID: 36437182
[TBL] [Abstract][Full Text] [Related]
9. [Digital health applications (DiGA) in the area of tension between progress and criticism : Discussion paper from the "Digital health" specialist group of the German Informatics Society].
Schlieter H; Kählig M; Hickmann E; Fürstenau D; Sunyaev A; Richter P; Breitschwerdt R; Thielscher C; Gersch M; Maaß W; Reuter-Oppermann M; Wiese L
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Jan; 67(1):107-114. PubMed ID: 38086924
[TBL] [Abstract][Full Text] [Related]
10. Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation.
Brönneke JB; Herr A; Reif S; Stern AD
Int J Technol Assess Health Care; 2023 Nov; 39(1):e72. PubMed ID: 37973549
[TBL] [Abstract][Full Text] [Related]
11. [Evidence of positive care effects by digital health apps-methodological challenges and approaches].
König IR; Mittermaier M; Sina C; Raspe M; Stais P; Gamstätter T; Stachwitz P; Wolfrum S; Richter JG; Möckel M;
Inn Med (Heidelb); 2022 Dec; 63(12):1298-1306. PubMed ID: 36279007
[TBL] [Abstract][Full Text] [Related]
12. [Digital health applications: statutory introduction of patient-centred digital innovations into healthcare].
Ludewig G; Klose C; Hunze L; Matenaar S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1198-1206. PubMed ID: 34529096
[TBL] [Abstract][Full Text] [Related]
13. Market access and value-based pricing of digital health applications in Germany.
Gensorowsky D; Witte J; Batram M; Greiner W
Cost Eff Resour Alloc; 2022 Jun; 20(1):25. PubMed ID: 35698135
[TBL] [Abstract][Full Text] [Related]
14. The German Fast Track Toward Reimbursement of Digital Health Applications: Opportunities and Challenges for Manufacturers, Healthcare Providers, and People With Diabetes.
Schliess F; Affini Dicenzo T; Gaus N; Bourez JM; Stegbauer C; Szecsenyi J; Jacobsen M; Müller-Wieland D; Kulzer B; Heinemann L
J Diabetes Sci Technol; 2024 Mar; 18(2):470-476. PubMed ID: 36059268
[TBL] [Abstract][Full Text] [Related]
15. One year of digital health applications (DiGA) in Germany - Rheumatologists' perspectives.
Richter JG; Chehab G; Stachwitz P; Hagen J; Larsen D; Knitza J; Schneider M; Voormann A; Specker C
Front Med (Lausanne); 2022; 9():1000668. PubMed ID: 36388899
[TBL] [Abstract][Full Text] [Related]
16. Integration of digital health applications into the German healthcare system: development of "The DiGA-Care Path".
Giebel GD; Abels C; Börchers K; Kampka B; Neusser S; Cissarek HR; Plescher F; Wasem J; Blase N
Front Health Serv; 2024; 4():1372522. PubMed ID: 38545382
[TBL] [Abstract][Full Text] [Related]
17. Critical success factors for creating sustainable digital health applications: A systematic review of the German case.
Schramm L; Carbon CC
Digit Health; 2024; 10():20552076241249604. PubMed ID: 38665883
[TBL] [Abstract][Full Text] [Related]
18. [Digital health applications (DiGA) on the road to success-the perspective of the German Digital Healthcare Association].
Geier AS
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Oct; 64(10):1228-1231. PubMed ID: 34524478
[TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
20. ["Alternative study designs" for the evaluation of digital health applications - a real alternative?].
Gensorowsky D; Lampe D; Hasemann L; Düvel J; Greiner W
Z Evid Fortbild Qual Gesundhwes; 2021 Apr; 161():33-41. PubMed ID: 33642251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
